Business Standard

Sun Pharma gains on acquisition of URL generic biz

Upon completion of the purchase, the non-colcrys generic assets of URL Pharma will be owned and managed by Caraco.

Related News

Sun Pharmaceutical Industries is trading higher by 2% at Rs 732 after the company said it has buys generic business of pharma through its subsidiary for an undisclosed amount.

“Caraco Pharmaceutical Laboratories, wholly-owned subsidiary of the company, has entered into a definitive agreement with Pharmaceuticals U.S.A., Inc, a wholly-owned subsidiary of Takeda Pharmaceutical Company, to buy the URL Pharma, Inc. generic business,” said in a statement.

Upon completion of the purchase, the non-colcrys generic assets of URL Pharma will be owned and managed by Caraco. The deal is subject to satisfaction of customary closing conditions, including applicable regulatory approvals, it added.

The stock opened at Rs 727 and hit a high of Rs 733 on the NSE. A combined 138,547 shares have changed hands on the counter in morning deals.

Read more on:   
|
|

Read More

Two entities fail to make prima facie case to revoke ban: Sebi

The Securities and Exchange Board of India (Sebi) today said the restraining order on two entities, related to plunge in some mid-cap stocks in July, ...

Quick Links

 

Market News

Reliance Petroinvestments' appeal adjourned by SAT till Sept 30

Sebi in May 2013 had imposed a penalty of Rs 11 cr on Reliance Petroinvestments in an insider trading case

Today's picks- 3 September 2014

Nifty, Bank Nifty, Bharti Airtel, Tech Mahindra & Tata Power

Let's make some money

Market experts say booking profits could be unwise. If you are nervous, go for dividend-yield stocks

Steel firms increase prices

This comes amid a rise in transportation costs and high iron ore prices; long-steel producers keep prices unchanged

Rubber imports set to soar

Military junta of Thailand, world's largest exporter of rubber, recently decided to release 200,000 tones of stock pile

Back to Top